ArticleScientific reports2019

PCC0208027, a novel tyrosine kinase inhibitor, inhibits tumor growth of NSCLC by targeting EGFR and HER2 aberrations.

Qiuju Dong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.